Recently, ALB has also been reported to promote immunotherapy response by facilitating ubiquitin-mediated PD-L1 degradation in melanoma models [62]; likewise, MLT has shown antitumor potential by impairing many of the characteristics that sustain cancer progression [63], highlighting the importance of discovering other potential mechanisms of action that could benefit the current treatment of patients with cancer. This evidence concerns the gene CD274 and melanoma.